Subscribe

Value-Based Concerns of European Oncologists

VBCC - Media Library - Pricing
Andrew Stainthorpe, PhD

The main value‑based concerns for oncologists are to have a good range of medicines, which give benefit to patients and have low side effects, so that there’s a suite of options for them to bring benefits to patients. Where other technologies might fail, you’ve got first, second, third line―a range of options for patients.

Related Items
Bringing the Patient into the Conversation
Andrew Stainthorpe, PhD
VBCC - Media Library published on March 25, 2015 in Personalized Medicine
Cost Is Crucial When Evaluating Treatment
Linda Bosserman, MD, FACP
VBCC - Media Library published on March 25, 2015 in Pricing
Value-Based Concerns - What Matters?
Linda Bosserman, MD, FACP
VBCC - Media Library published on March 25, 2015 in Pricing
Approaches to Alleviating Costs for Patients and Payers
Andrew Stainthorpe, PhD
VBCC - Media Library published on March 25, 2015 in Pricing
Keeping Cost Out of the Drug Approval Debate
Andrew Stainthorpe, PhD
VBCC - Media Library published on March 25, 2015 in Pricing
New Conversations About Costs of Cancer Care
C. Daniel Mullins, PhD
VBCC - Media Library published on March 25, 2015 in Pricing
Providing Patients with Cost Information
C. Daniel Mullins, PhD
VBCC - Media Library published on March 25, 2015 in Pricing
Affordability + Clinical Effectiveness = The Value Equation
C. Daniel Mullins, PhD
VBCC - Media Library published on March 25, 2015 in Pricing
Using Research to Guide Quality and Quantity of Care
Andrew Stainthorpe, PhD
VBCC - Media Library published on March 25, 2015 in Personalized Medicine
Weighing Cost and Care: An Oncologist's Debate
Andrew Stainthorpe, PhD
VBCC - Media Library published on March 25, 2015 in Personalized Medicine
Last modified: September 29, 2015
  • Rheumatology Practice Management
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology